Paragon Capital Management »

Regeneron Pharmaceuticals shares owned by Paragon Capital Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Paragon Capital Management from 13F filings

Historical chart of Paragon Capital Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Paragon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Paragon Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 2.2k 562.27
2025-06-30 $1.2M 2.2k 525.00
2025-03-31 $1.4M 2.2k 634.23
2024-12-31 $1.3M 1.8k 712.33
2021-12-31 $725k 1.1k 631.52

More positions owned by Paragon Capital Management

Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Tr Short Treas Bd (SHV)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ishares Tr Us Treas Bd Etf (GOVT)
Ssga Active Etf Tr Spdr Tr Tactic (TOTL)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Vanguard Index Fds Small Cp Etf (VB)
Meta Platforms Cl A (META)
O'reilly Automotive (ORLY)
MercadoLibre (MELI)
Ssga Active Tr Spdr Dbleln Shrt (STOT)
Lyft Cl A Com (LYFT)
IDEXX Laboratories (IDXX)
Booking Holdings (BKNG)

View all positions for Paragon Capital Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals